Brief: Innate Pharma To Present Updated Interim Phase 2 Efficacy Results Of Lacutamab In Mycosis Fungoides

Innate Pharma SA

12/06/2023 06:07

June 12 (Reuters) - Innate Pharma SA  IPH.PA :
    * TO PRESENT UPDATED INTERIM PHASE 2 EFFICACY RESULTS OF
LACUTAMAB
IN MYCOSIS FUNGOIDES AT INTERNATIONAL CONFERENCE ON MALIGNANT
LYMPHOMA

Source text for Eikon:  ID:nBwb9VBpka 
Further company coverage:  IPH.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))